Joseph C. Ward

Joseph C. Ward

Auto-generated profile, based on publicly available information

Joseph C. Ward

Translational Genomics, Centre of Genomics Research, Discovery Sciences, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2019 in Journal of General Virology
Verified
Journal Article
Open access
MHMorgan R. Herod
Morgan R. Herod
OAOluwapelumi Olufemi Adeyemi
Oluwapelumi Olufemi Adeyemi
JWJoseph Ward
Joseph Ward
KBKirsten Bentley
Kirsten Bentley
MHMark Harris
Mark Harris
SPStephen Polyak
Stephen Polyak
Arbidol (ARB, also known as umifenovir) is used clinically in several countries as an anti-influenza virus drug. ARB inhibits multiple enveloped viruses in vitro and the primary mode of action is inhibition of virus entry and/or fusion of viral membranes with intracellular endosomal membranes. ARB is also an effective inhibitor of non-enveloped poliovirus types 1 and 3. In the current report, we evaluate the antiviral potential of ARB against another picornavirus, foot-and-mouth disease virus (FMDV), a member of the genus Aphthovirus and an important veterinary pathogen. ARB inhibits the replication of FMDV RNA sub-genomic replicons. ARB inhibition of FMDV RNA replication is not a result of generalized inhibition of cellular uptake of cargo, such as transfected DNA, and ARB can be added to cells up to 3 h post-transfection of FMDV RNA replicons and still inhibit FMDV replication. ARB prevents the recovery of FMDV replication upon withdrawal of the replication inhibitor guanidine hydrochloride (GuHCl). Although restoration of FMDV replication is known to require de novo protein synthesis upon GuHCl removal, ARB does not suppress cellular translation or FMDV internal ribosome entry site (IRES)-driven translation. ARB also inhibits infection with the related Aphthovirus, equine rhinitis A virus (ERAV). Collectively, the data demonstrate that ARB can inhibit some non-enveloped picornaviruses. The data are consistent with inhibition of picornavirus genome replication, possibly via the disruption of intracellular membranes on which replication complexes are located.

1 November 2020 in Journal of General Virology
Verified
Journal Article
Open access
JWJoseph C. Ward
Joseph C. Ward
SBSebastian Bowyer
Sebastian Bowyer
SCShucheng Chen
Shucheng Chen
GCGuilherme Campos
Guilherme Campos
SASantseharay Ramirez Almeida
Santseharay Ramirez Almeida
MHMark Harris
Mark Harris
Hepatitis C virus (HCV) is an important human pathogen causing 400 000 chronic liver disease-related deaths annually. Until recently, the majority of laboratory-based investigations into the biology of HCV have focused on the genotype 2 isolate, JFH-1, involving replicons and infectious cell culture systems. However, genotype 2 is one of eight major genotypes of HCV and there is great sequence variation among these genotypes (>30 % nucleotide divergence). In this regard, genotype 3 is the second most common genotype and accounts for 30 % of global HCV cases. Further, genotype 3 is associated with both high levels of inherent resistance to direct-acting antiviral (DAA) therapy, and a more rapid progression to chronic liver diseases. Neither of these two attributes are fully understood, thus robust genotype 3 culture systems to unravel viral replication are required. Here we describe the generation of robust genotype 3 sub-genomic replicons (SGRs) based on the adapted HCV NS3-NS5B replicase from the DBN3a cell culture infectious clone. Such infectious cell culture-adaptive mutations could potentially promote the development of robust SGRs for other HCV strains and genotypes. The novel genotype 3 SGRs have been used both transiently and to establish stable SGR-harbouring cell lines. We show that these resources can be used to investigate aspects of genotype 3 biology, including NS5A function and DAA resistance. They will be useful tools for these studies, circumventing the need to work under the biosafety level 3 (BSL3) containment required in many countries.

1 January 2021 in Journal of General Virology
Verified
Journal Article
Open access
GCGuilherme Campos
Guilherme Campos
JWJoseph Ward
Joseph Ward
SCShucheng Chen
Shucheng Chen
CBCíntia Bittar
Cíntia Bittar
JRJoão Paulo Vilela Rodrigues
João Paulo Vilela Rodrigues
MHMark Harris
Mark Harris
Hepatitis C virus (HCV) genotype 3 presents a high level of both baseline and acquired resistance to direct-acting antivirals (DAAs), particularly those targeting the NS5A protein. To understand this resistance we studied a cohort of Brazilian patients treated with the NS5A DAA, daclatasvir and the nucleoside analogue, sofosbuvir. We observed a novel substitution at NS5A amino acid residue 98 [serine to glycine (S98G)] in patients who relapsed post-treatment. The effect of this substitution on both replication fitness and resistance to DAAs was evaluated using two genotype 3 subgenomic replicons. S98G had a modest effect on replication, but in combination with the previously characterized resistance-associated substitution (RAS), Y93H, resulted in a significant increase in daclatasvir resistance. This result suggests that combinations of substitutions may drive a high level of DAA resistance and provide some clues to the mechanism of action of the NS5A-targeting DAAs.

18 December 2025 in Journal of Chromatography A
Verified
Journal Article
Closed access
MEMayada Elgohary
Mayada Elgohary
AWAlexandra L.J. Webb
Alexandra L.J. Webb
JWJoseph C. Ward
Joseph C. Ward
AMAndal Murthy
Andal Murthy
JHJack Hutchinson
Jack Hutchinson
EÖEivor Örnskov
Eivor Örnskov

28 July 2024 in The FASEB Journal
Verified
Journal Article
Open access
JWJoseph C. Ward
Joseph C. Ward
LLLidia Lasecka-Dykes
Lidia Lasecka-Dykes
SDSam Dobson
Sam Dobson
SGSarah Gold
Sarah Gold
NKNatalie Jean Kingston
Natalie Jean Kingston
NSNicola Stonehouse
Nicola Stonehouse
Secondary and tertiary RNA structures play key roles in genome replication of single‐stranded positive sense RNA viruses. Complex, functional structures are particularly abundant in the untranslated regions of picornaviruses, where they are involved in initiation of translation, priming of new strand synthesis and genome circularization. The 5′ UTR of foot‐and‐mouth disease virus (FMDV) is predicted to include a c. 360 nucleotide‐long stem‐loop, termed the short (S) fragment. This structure is highly conserved and essential for viral replication, but the precise function(s) are unclear. Here, we used selective 2′ hydroxyl acetylation analyzed by primer extension (SHAPE) to experimentally determine aspects of the structure, alongside comparative genomic analyses to confirm structure conservation from a wide range of field isolates. To examine its role in virus replication in cell culture, we introduced a series of deletions to the distal and proximal regions of the stem‐loop. These truncations affected genome replication in a size‐dependent and, in some cases, host cell‐dependent manner. Furthermore, during the passage of viruses incorporating the largest tolerated deletion from the proximal region of the S fragment stem‐loop, an additional mutation was selected in the viral RNA‐dependent RNA polymerase, 3D pol . These data suggest that the S fragment and 3D pol interact in the formation of the FMDV replication complex.